Maharishi Glucomap
Product Description :
Glucomap is a rational combination of herbal hypoglycaemias known since ages and duly accredited by laboratory and clinical studies.
Glucomap has both pancreatic as well as extra pancreatic action (Momordica cherantia and Eugenia jambolana).
Glucomap stimulates beta cells of pancreas (Aegle marmelos), increases peripheral utilisation of glucose and arrests glycogenolysis.
Glucomap protects cardiovascular and nerve tissues from degenerative changes (Terminaliaarjuna), protects the liver and strengthens its function (phyllanthus niruri).
The immuno-regulator, Asphaltum in Glucomap arrests metabolic abnormalities and reduces recurrent infections. Salsaradigan of Glucomap gives an umbrella of protection against all pervasive degeneration in diabetes
Helps alone or as an adjuvant with other OHA in stabilizing blood sugar in type II patients.
During clinical trials, Glucomap was found to be extremely well tolerated even in doses as high as 16 tablets a day. Significantly, almost all patients had such improved subjective feelings as never experienced with other anti-diabetic therapies.
Indications:
Non- insulin dependent Diabetes mellitus. As an adjuvant to other anti-diabetic drugs.
Ingredients:
- Each 500mg tablet contains:
- Enicostemma littorale 33.33mg
- Phyllanthus niruri 33.33mg
- Eugenia jambolana 33.33mg (leaf)
- Eugenia jambolana (seed) 133.33mg
- Azadirachta indica 33.33mg
- Terminalia arjuna 33.33mg
- Aegle marmelos 133.33mg
- Asphaltum 66.66mg
Processed in the aqueous extract of Bilva (Aegle marmelos), Karavellaka (Momordica cherantia) and Salsaradigan.
Dosage: 1-2 Tablets twice a day or as directed by the physician.
Packaging: Each Box contains 10 strips of 10 tablets each, totalling 100 tablets of 500 mg each.
